The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for ...

Excellergy is developing medicines that combat allergic responses in three different ways, a multipronged effect the company says could lead to faster and more complete disease control.

EcoFlow just announced its latest “most powerful” and “easy-to-install” whole-home battery backup system. It’s called the ...

That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic ...

Dr. Wang, who also serves as the founding director for research in the Division of Data Science, is leading efforts to create ...

Mexican scientist Mario Molina, who became his country's first winner of the Nobel Prize for Chemistry for his work on the threat to the ozone layer from chlorofluorocarbons (CFCs), died on Wednesday ...

FoLix, the FDA-cleared laser treatment for hair loss, provides a surgery-free option and uses existing follicles on men and women.

Leon and colleagues have published studies showing older adults' brain activity and memory improved significantly when ...

As demand for data centers skyrockets, Nexalus Liquid Cooling’s solution is to seal the servers off and create a closed-loop ...

Celltrion’s Omlyclo™, the first and only omalizumab biosimilar in Europe, will be commercially available starting in Norway, with subsequent rollouts in European countries Results from the global ...